Power Wheelchair Group 3 denied as not FDA-approved for this use by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for power wheelchair group3 are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Denies Power Wheelchair (Group 3) as Not FDA-Approved

Power wheelchairs — including Group 3 complex rehabilitation technology (CRT) — are regulated by the FDA as Class II medical devices and require 510(k) clearance before they can be marketed and sold in the United States. A not-FDA-approved denial typically arises in one of three scenarios: (1) a specific component or accessory added to the chair (such as a custom seating system, ventilator tray, or novel drive-control interface) lacks its own clearance; (2) the device is being used in a configuration or for an indication outside its cleared labeling; or (3) the denial was generated in error — the device does carry clearance but the claim lacked documentation of it. All three scenarios are addressable on appeal.

This denial is often overturned when the prescriber or supplier provides the FDA 510(k) clearance number for the device and each major component, confirming regulatory status.

## Your Federal Appeal Rights

Under ACA §2719, you have the right to independent external review by a certified IRO after exhausting UHC's internal appeals. Under ERISA §503 (self-funded plans), you are entitled to full-and-fair review with access to the rationale used. The external-review window is generally approximately four months from the date of denial notice. Request expedited review if the lack of the device poses an imminent clinical risk.

## Documentation to Gather

• FDA 510(k) clearance documentation: your DME supplier should be able to provide the 510(k) clearance number for the power wheelchair and each key component. You can also verify clearance through the FDA's publicly searchable 510(k) database.
• HCPCS coding confirmation: confirm that the device is billed under a recognized HCPCS code; CMS-assigned codes are a strong indicator that the device category is recognized and cleared.
• Manufacturer documentation: the manufacturer's regulatory affairs documentation confirming the device's FDA-cleared status and cleared indications.
• Prescriber letter addressing FDA status: if the denial targets a specific component or use configuration, your physician should explain how the prescribed use falls within the device's cleared indications and why it is medically necessary.

## Criteria-Mapping Structure

Directly rebut the not-FDA-approved rationale item by item:

| UHC's Specific Denial Basis | Documentation Rebutting It | |---|---| | Entire device not cleared | [510(k) clearance number + FDA database reference] | | Specific component questioned | [Component-level 510(k) or manufacturer letter] | | Use outside cleared labeling | [Physician letter confirming on-label use; clinical chart] |

A concise table showing that each questioned element carries the appropriate regulatory clearance is frequently sufficient to have this type of denial reversed at the first level of internal appeal.